Urticaria pigmentosa responsive to nifedipine

Area of Science:

• Dermatology
• Pharmacology
• Cell Biology

Background:

• Urticaria pigmentosa is a rare skin condition characterized by mast cell accumulation.
• Mast cell degranulation leads to the release of histamine and other mediators, causing urticarial lesions and flushing.
• Cold exposure can trigger mast cell degranulation in susceptible individuals.

Observation:

• A patient with symptomatic urticaria pigmentosa experienced relief from cold-induced urtication and flushing.
• The patient was treated with nifedipine, a calcium channel blocker, at a dosage of 10 mg orally three times daily.
• Symptomatic improvement was noted with this therapeutic intervention.

Findings:

• Nifedipine therapy provided significant relief for the patient's urticaria pigmentosa symptoms.
• The observed therapeutic effect suggests a role for calcium influx in mast cell degranulation.
• Calcium channel blockade by nifedipine is hypothesized to increase the threshold for mast cell degranulation.

Implications:

• Nifedipine may be a potential therapeutic option for managing symptomatic urticaria pigmentosa, particularly symptoms triggered by cold.
• Understanding the role of calcium channels in mast cell degranulation could lead to novel treatment strategies for mast cell-mediated disorders.
• This case report highlights the importance of exploring pharmacological interventions targeting ion channels in dermatological conditions.